Prospective, Randomized, Controlled, Clinical Study on Tolerability and Efficacy of hMG-IBSA
Status:
Completed
Trial end date:
2005-04-01
Target enrollment:
Participant gender:
Summary
Purpose of the study is the evaluation of the tolerability (both local and systemic) and the
clinical efficacy (in terms oocytes recovered) of subcutaneously versus intramuscularly
administered Merional® (IBSA, Lugano - CH) in patients undergoing controlled ovarian
hyperstimulation (COH) in an ART programme (IVF).